SCHEMBL25519701

SCHEMBL25519701

COC(=O)c1ccc2nc(NN)c(Cl)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.43
▸ RHEB Q15382 1/20 0.42
▸ TP53 P04637 2/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ LCK P06239 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ PI4KB Q9UBF8 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HPGD P15428 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23774957 0.83 HTT (0.51) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL23756437 0.82 HTT (0.54) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL18369634 0.81 HTT (0.52) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL25519704 0.81 PDK1 (0.46) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL1721301 0.81 CSNK2A1 (0.48) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL18370845 0.80 HTT (0.51) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL23756529 0.77 VNN1 (0.47) HTTALDH1A1TP53MAPTKMT2A
Trifluoroacetic Acid SCHEMBL23757320 0.76 KDM4E (0.45) HTTALOX15ALDH1A1RHEBTP53
SCHEMBL31544152 0.75 HTT (0.52) HTTALOX15ALDH1A1TP53KDM4E
SCHEMBL1535334 0.75 HTT (0.59) HTTALOX15ALDH1A1RHEBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159510-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159510-A1 NOVEL PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 HTT 3702/4885ALOX15 3322/4885ALDH1A1 3191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback